NASDAQ:SSRX

3SBio Inc. Announces Unaudited First Quarter 2012 Results

SHENYANG, China, May 13, 2012 /PRNewswire-Asia/ -- 3SBio Inc. (NASDAQ: SSRX) ("3SBio" or "the Company"), a leading China-based biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, today announced its unaudited financial results for the fir...

2012-05-14 08:17 1027

3SBio Inc. Files Annual Report on Form 20-F for Fiscal Year 2011

SHENYANG, China, April 30, 2012 /PRNewswire-Asia/ -- 3SBio Inc. (NASDAQ: SSRX) ("3SBio" or "the Company"), a leading China-based biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, today announced that it has filed the Company's Annual Re...

2012-05-01 10:21 966

3SBio Inc. Schedules Unaudited First Quarter 2012 Results

SHENYANG, China, April 23, 2012 /PRNewswire-Asia/ -- 3SBio Inc. (NASDAQ: SSRX) ("3SBio"), a leading China-based biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, today announced that it will release its unaudited first quarter 2012 resu...

2012-04-24 10:00 740

3SBio Inc. Announces Changes to its Board of Directors

SHENYANG, China, March 21, 2012 /PRNewswire-Asia/ -- 3SBio Inc. (NASDAQ: SSRX) ("3SBio" or "the Company"), a leading China-based biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, today announced changes to its board of directors (the "B...

2012-03-21 22:36 896

3SBio Inc. Announces Unaudited Fourth Quarter and Full Year 2011 Results

SHENYANG, China, March 8, 2012 /PRNewswire-Asia/ -- 3SBio Inc. (NASDAQ: SSRX) ("3SBio" or "the Company"), a leading China-based biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, today announced its unaudited financial results for the fo...

2012-03-09 09:00 1163

3SBio and DaVita Collaborate on Dialysis Clinics in Northeastern China

SHENYANG, China, March 8, 2012 /PRNewswire-Asia/ -- 3SBio Inc. (NASDAQ: SSRX) ("3SBio") a leading China-based biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, today announced a collaboration agreement with DaVita Inc. (NYSE: DVA), a le...

2012-03-09 05:00 967

3SBio Inc. to Present at the Oppenheimer & Co. 6th Annual China Dragon Conference

SHENYANG, China, Feb. 7, 2012 /PRNewswire-Asia-FirstCall/ -- 3SBio Inc. (NASDAQ: SSRX) ("3SBio"), a leading China-based biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, today announced that Dr. Jing Lou, chief executive officer, and Mr...

2012-02-07 16:52 1063

3SBio Inc. Schedules Unaudited Fourth Quarter and Full Year 2011 Results

SHENYANG, China, Feb. 3, 2012 /PRNewswire-Asia-FirstCall/ -- 3SBio Inc. (NASDAQ: SSRX) ("3SBio"), a leading China-based biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, today announced that it will release its unaudited fourth quarter ...

2012-02-03 22:42 860

3SBio Inc. Announces Unaudited Third Quarter 2011 Results

SHENYANG, China, Nov. 10, 2011 /PRNewswire-Asia-FirstCall/ --* *3SBio Inc. (NASDAQ: SSRX) ("3SBio" or "the Company"), a leading China-based biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, today announced its unaudited financial result...

2011-11-11 09:00 1274

3SBio Inc. Schedules Unaudited Third Quarter 2011 Results

SHENYANG, China,* *Oct. 20, 2011 /PRNewswire-Asia-FirstCall/ -- 3SBio Inc. (NASDAQ: SSRX) ("3SBio" or "the Company"), a leading China-based biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, today announced that it will release its unaud...

2011-10-20 14:59 976

3SBio Inc. Announces Results of 2011 Annual General Meeting

SHENYANG, China, Sept. 21, 2011 /PRNewswire-Asia-FirstCall/ -- 3SBio Inc. (Nasdaq: SSRX) ("3SBio" or "Company"), a leading China-based biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, today announced the results of shareholder votes at...

2011-09-21 18:03 1069

3SBio Inc. to Hold 2011 Annual General Meeting on September 20, 2011

SHENYANG, China, Aug. 20, 2011 /PRNewswire-Asia-FirstCall/ -- 3SBio Inc. (NASDAQ: SSRX) ("3SBio" or "Company"), a leading China-based biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, today announced that the annual general meeting of s...

2011-08-20 12:23 927

3SBio Inc. Announces Unaudited Second Quarter and First Half 2011 Results

SHENYANG, China, Aug. 15, 2011 /PRNewswire-Asia-FirstCall/ -- 3SBio Inc. (NASDAQ: SSRX) ("3SBio" or "the Company"), a leading China-based biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, today announced its unaudited financial results ...

2011-08-16 08:00 1208

3SBio Inc. Schedules Unaudited Second Quarter 2011 Results

SHENYANG, China, July 22, 2011 /PRNewswire-Asia-FirstCall/ -- 3SBio Inc. (NASDAQ: SSRX) ("3SBio" or "the Company"), a leading China-based biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, today announced that it will release its unaudit...

2011-07-22 14:49 973

3SBio Inc. Announces Unaudited First Quarter 2011 Results

Net revenues grew 22.7% year-on-year to RMB118.2 million (US$18.1 million) Reiterates 2011 net revenues guidance of US$76-US$82 million Submitted application to conduct clinical trials of voclosporin in China Seeking regulatory approval for EPIAO in selected PICS markets SHENYANG, Ch...

2011-05-12 08:00 797

3SBio Inc. Schedules Unaudited First Quarter 2011 Results

SHENYANG, China, May 3, 2011 /PRNewswire-Asia-FirstCall/ -- 3SBio Inc. (NASDAQ: SSRX) ("3SBio" or "the Company"), a leading China-based biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, today announced that it will release its first qua...

2011-05-03 23:11 1340

3SBio Inc. Announces Unaudited Fourth Quarter and Full Year 2010 Results

2010 revenues grew 32.1% to RMB418.6 million (US$63.4 million) 2011 revenues expected to grow 20%-30% to US$76-US$82 million New GMP-certified plant to support domestic and international growth Secured new phase I and phase II compounds with significant unmet medical needs SHENYANG, China, M...

2011-03-16 08:00 1205

3SBio Inc. Schedules Unaudited Fourth Quarter and Fiscal Year 2010 Results

SHENYANG, China, Feb. 19, 2011 /PRNewswire-Asia-FirstCall/ -- 3SBio Inc. (Nasdaq: SSRX) ("3SBio" or "the Company"), a leading China-based biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, today announced that it will release unaudited f...

2011-02-21 07:20 865

3SBio Inc. Receives SFDA Approval for TPIAO Label Extension for the Treatment of ITP

SHENYANG, China, Jan. 25, 2011 /PRNewswire-Asia-FirstCall/ -- 3SBio Inc. (Nasdaq: SSRX) ("3SBio" or " Company"), a leading China-based biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, today announced that it has received official notif...

2011-01-25 09:00 876
12345